Treatment of protein-losing gastropathy with atropine.
Protein loss from the gastric mucosa with hypertrophic gastric folds and hypoalbuminemia has been associated with low, normal and elevated gastric acid output. A case of protein-losing gastropathy with slightly elevated gastric acid output is described. Associated findings were hypertrophic gastric folds, hypoalbuminemia, hyperlipidemia, lymphadenopathy, edema, ascites and venous thrombosis. Oral administration of atropine resulted in a cessation of gastrointestinal protein loss and correction of hypoalbuminemia.
D000143:Acids / Q000378:metabolism; D000419:Albuminuria / Q000150:complications; D001201:Ascites / Q000150:complications; D001285:Atropine / Q000627:therapeutic use*; D004487:Edema / Q000150:complications; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D008875:Middle Aged; D011506:Proteins / Q000378:metabolism*; D013272:Stomach Diseases / Q000188:drug therapy / Q000378:metabolism*; D013924:Thrombophlebitis / Q000150:complications
D000143:Acids; D011506:Proteins; D001285:Atropine